Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Eisai and Sysmex said on February 15 that they have inked a comprehensive non-exclusive collaboration pact in a bid to create new diagnostics in the field of dementia that can be used in an easy, affordable, and low-invasive fashion. The…
To read the full story
Related Article
- Alzheimer’s Disease Might Be Diagnosed by Blood Sample: Sysmex, Eisai
December 10, 2019
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





